Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nicast To Exhibit and Present Results of the AVflo™ Clinical

Abstract:
Trial at the Charing Cross 31st International Symposium in London



Nicast plans to begin post marketing clinical studies in Europe in 2009

Nicast To Exhibit and Present Results of the AVflo™ Clinical

Lod, Israel | Posted on March 12th, 2009

Nicast, developer of medical devices made of electrospun nanofabric, announced today that it will exhibit the AVflo™ vascular access graft for hemodialysis, its flagship product which received CE certification in October 2008, at the Charing Cross 31st International Symposium in London, April 4-7, 2009, booth number 154.

During the conference, Professor S Mandika Wijeyaratne, MBBS MS MD (Leeds) FRCS(Eng), Professor in Surgery, University of Colombo, Consultant Vascular & Transplant Surgeon, National Hospital Colombo, Sri Lanka and the PI of the AVFlo clinical study, will address participants on the topic "Safety and efficacy of a new polycarbonate-urethane graft for early vascular access in end stage renal disease: First clinical results in man". The presentation will take place on Sunday, April 5th at 16:50 at the CX "New Technology Dragon's Den" Learning Center 3. Professor Wijeyaratne will also be available during the conference at Nicast's booth to answer any questions.

AVflo is a self-sealing vascular access graft that enables unobstructed blood flow, allows for dialysis within 24-48 hours after implantation and self-seals within less than five minutes following withdrawal of the dialysis needles. It is simple to implant and to suture to blood vessels; the needle punctures and suture holes self-seal rapidly. AVflo is also strong enough to withstand the pressure of blood flow, yet thin enough for blood flow to be easily felt through it.

"This is an exciting time for Nicast as we are transitioning from a pre-sales company to a revenue generating company. We already have sales of AVflo in Europe and South East Asia, and we are expanding our network of select distributors in key countries. Nicast is also planning to commence in the near future a post marketing multi-site clinical study of AVflo in Europe," said Mr. Benjamin Eliason, CEO of Nicast.

"The medical community has been quite impressed with Nicast's electrospinning technology and products. We are enjoying an unprecedented level of interest in pursuing joint projects, a topic we are always open to discussing," said Dr. Jacob Dagan, chairman of the board of Nicast.

Details of the studies will be released in a future communication.

####

About Nicast Ltd.
Nicast Ltd. is a pioneer in the development of superior implantable medical devices made of electrospun polymer nanofabrics for a wide range of applications. The company is currently focused on the development and marketing of the AVflo vascular access graft and the NovaMesh ventral hernia mesh, which address a combined global market of $0.7 billion to $1 billion. Headquartered in Lod, Israel, Nicast has six patents in the U.S., ten patents outside of the U.S. and 14 additional patents pending.

For more information, please click here

Contacts:
Marjie Hadad
media liaison
+972-54-536-5220

Copyright © Nicast Ltd.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Discovery of nanotubes offers new clues about cell-to-cell communication July 2nd, 2015

Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015

Engineering the world’s smallest nanocrystal July 2nd, 2015

Producing spin-entangled electrons July 2nd, 2015

Nanomedicine

Iranian Scientists Find Simple, Economic Method to Synthesize Antibacterial Nanoparticles July 2nd, 2015

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Carnegie Mellon chemists characterize 3-D macroporous hydrogels: Methods will allow researchers to develop new 'smart' materials June 30th, 2015

Chitosan coated, chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015

Announcements

Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015

Engineering the world’s smallest nanocrystal July 2nd, 2015

Producing spin-entangled electrons July 2nd, 2015

NIST Group Maps Distribution of Carbon Nanotubes in Composite Materials July 2nd, 2015

Events/Classes

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems June 29th, 2015

Graphene breakthrough as Bosch creates magnetic sensor 100 times more sensitive than silicon equivalent June 28th, 2015

Spain nanotechnology featured at NANO KOREA 2015 June 26th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project